$KAVL
Kaival Brands Innovations Group, Inc. Stock $kavl

$kavl Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000173112224000237 Filed on February 14, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$3.212M	$3.957M	$13.09M
YoY Change	27.14%	31.37%	2.55%
Cost Of Revenue	$2.013M	$3.098M	$10.51M
YoY Change	1.39%	62.21%	-8.75%
Gross Profit	$1.198M	$858.8K	$2.575M
YoY Change	121.83%	-22.08%	107.46%
Gross Profit Margin	37.31%	21.7%	19.67%
Selling, General & Admin	$2.716M	$2.901M	$13.24M
YoY Change	-23.42%	-24.34%	-15.3%
% of Gross Profit	226.7%	337.74%	514.2%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$196.8K	$198.3K	$328.3K
YoY Change	169529.31%
% of Gross Profit	16.42%	23.09%	12.75%
Operating Expenses	$2.913M	$2.901M	$13.24M
YoY Change	-17.88%	-24.34%	-15.3%
Operating Profit	-$1.715M	-$2.042M	$23.80M
YoY Change	-42.98%	-25.26%	428.89%
Interest Expense	-$299.9K	-$331.4K	-$466.5K
YoY Change	-2609.79%
% of Operating Profit			-1.96%
Other Income/Expense, Net	-$398.3K		-$466.5K
YoY Change	-3432.91%		-11663175.0%
Pretax Income	-$2.113M	-$2.373M	-$11.13M
YoY Change	-29.45%	-13.12%	-22.64%
Income Tax	$720.00	$2.350K	$2.348K
% Of Pretax Income
Net Earnings	-$2.181M	-$2.443M	-$11.13M
YoY Change	-27.17%	-10.16%	-22.53%
Net Earnings / Revenue	-67.92%	-61.74%	-85.07%
Basic Earnings Per Share	-$0.76		-$4.13
Diluted Earnings Per Share	-$0.76	-$0.88	-$4.13
COMMON SHARES
Basic Shares Outstanding	2.846M shares		2.721M shares
Diluted Shares Outstanding	2.855M shares		2.721M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$591.3K	$533.7K	$533.7K
YoY Change	-84.33%	-85.52%	-85.52%
Cash & Equivalents	$0.00	$533.7K
Short-Term Investments
Other Short-Term Assets	$369.0K	$430.7K	$430.7K
YoY Change	16.55%	1.0%	1.0%
Inventory	$2.331M	$4.072M	$4.072M
Prepaid Expenses	$369.0K	$430.7K
Receivables	$744.0K	$1.869M	$1.869M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$4.035M	$6.905M	$6.905M
YoY Change	-61.18%	-23.89%	-23.89%
LONG-TERM ASSETS
Property, Plant & Equipment	$962.3K	$1.011M	$1.011M
YoY Change	-16.71%	-15.66%	-15.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.668K	$2.842K
YoY Change	-20.69%
Total Long-Term Assets	$12.23M	$12.48M	$12.48M
YoY Change	363.64%	271.02%	271.02%
TOTAL ASSETS
Total Short-Term Assets	$4.035M	$6.905M	$6.905M
Total Long-Term Assets	$12.23M	$12.48M	$12.48M
Total Assets	$16.27M	$19.39M	$19.39M
YoY Change	24.81%	55.87%	55.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.718M	$374.3K	$2.849M
YoY Change	2014.43%	835.29%	7019.32%
Accrued Expenses	$884.8K	$736.2K	$920.8K
YoY Change	30.99%	-33.02%	-27.22%
Deferred Revenue
YoY Change
Short-Term Debt	$821.9K	$799.5K	$799.5K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.704M	$4.962M	$4.962M
YoY Change	-2.18%	212.95%	212.95%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$817.1K	$866.2K	$866.2K
YoY Change	-18.81%	-17.57%	-17.57%
Total Long-Term Liabilities	$817.1K	$866.2K	$866.2K
YoY Change	-18.81%	-17.57%	-17.57%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.704M	$4.962M	$4.962M
Total Long-Term Liabilities	$817.1K	$866.2K	$866.2K
Total Liabilities	$4.522M	$5.828M	$5.828M
YoY Change	-5.67%	121.07%	121.07%
SHAREHOLDERS EQUITY
Retained Earnings	-$32.88M	-$30.76M
YoY Change	45.31%	56.71%
Common Stock	$2.863K	$2.793K
YoY Change	-94.9%	-95.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$11.75M	$13.56M	$13.56M
YoY Change
Total Liabilities & Shareholders Equity	$16.27M	$19.39M	$19.39M
YoY Change	24.81%	55.87%	55.87%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$2.181M	-$2.443M	-$11.13M
YoY Change	-27.17%	-10.16%	-22.53%
Depreciation, Depletion And Amortization	$196.8K	$198.3K	$328.3K
YoY Change	169529.31%
Cash From Operating Activities	$244.9K	-$123.3K	-$2.973M
YoY Change	168.48%	-144.97%	-47.88%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$3.480K	$3.480K
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities		-$2.290K	-$312.3K
YoY Change
Cash From Investing Activities	$0.00	$4.230K	-$315.8K
YoY Change	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-187.3K	-343.2K	$136.8K
YoY Change		-738.89%	-91.26%
NET CHANGE
Cash From Operating Activities	244.9K	-123.3K	-$2.973M
Cash From Investing Activities	0.000	4.230K	-$315.8K
Cash From Financing Activities	-187.3K	-343.2K	$136.8K
Net Change In Cash	57.64K	-462.2K	-$3.152M
YoY Change	-34.3%	-241.02%	-23.85%
FREE CASH FLOW
Cash From Operating Activities	$244.9K	-$123.3K	-$2.973M
Capital Expenditures	$0.00	$3.480K	$3.480K
Free Cash Flow	$244.9K	-$126.7K	-$2.977M
YoY Change	179.12%		-47.82%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001762239
CY2022	kavl	Converted Series Convertible Preferred Stock ConvertedSeriesConvertiblePreferredStock		usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2023	kavl	Settled Rsus With Cash SettledRsusWithCash		usd
CY2022	kavl	Insurance Financed By Third Party InsuranceFinancedByThirdParty		usd
CY2022	kavl	Common Stock Issued For Note Payable Financing CommonStockIssuedForNotePayableFinancing		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-10-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--10-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-04641
CY2023	dei	Entity Registrant Name EntityRegistrantName	Kaival Brands Innovations Group, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-3492907
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	4460 Old Dixie Highway
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Grant-Valkaria
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32949
CY2023	dei	City Area Code CityAreaCode	(833)
CY2023	dei	Local Phone Number LocalPhoneNumber	452-4825
CY2023	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2023	dei	Trading Symbol TradingSymbol	KAVL
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	33701454	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2846335	shares
CY2023	dei	Auditor Firm AuditorFirmId	206
CY2023	dei	Auditor Name AuditorName	MaloneBailey, LLP
CY2023	dei	Auditor Location AuditorLocation	Houston, Texas
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	533659	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3685893	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1869276	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	574606	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	0	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1539486	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	4071824	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1239725	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	430668	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	426407	usd
CY2023Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	0	usd
CY2022Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	1607302	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	6905427	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	9073419	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2842	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	0	usd
CY2023Q4	kavl	Intangible Assets Non Current IntangibleAssetsNonCurrent	11468309	usd
CY2022Q4	kavl	Intangible Assets Non Current IntangibleAssetsNonCurrent	0	usd
CY2023Q4	us-gaap	Other Receivables OtherReceivables	0	usd
CY2022Q4	us-gaap	Other Receivables OtherReceivables	2164646	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1008428	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1198969	usd
CY2023Q4	us-gaap	Assets Assets	19385006	usd
CY2022Q4	us-gaap	Assets Assets	12437034	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	374332	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	40023	usd
CY2023Q4	kavl	Due To Other Related Party Classified Current DueToOtherRelatedPartyClassifiedCurrent	2474817	usd
CY2022Q4	kavl	Due To Other Related Party Classified Current DueToOtherRelatedPartyClassifiedCurrent	0	usd
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	799471	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	0	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	736194	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1099157	usd
CY2023Q4	us-gaap	Customer Deposits Current CustomerDepositsCurrent	0	usd
CY2022Q4	us-gaap	Customer Deposits Current CustomerDepositsCurrent	44973	usd
CY2023Q4	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	392406	usd
CY2022Q4	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	0	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	0	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	235274	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	184568	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	166051	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4961788	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1585478	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	866207	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1050776	usd
CY2023Q4	us-gaap	Liabilities Liabilities	5827995	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2636254	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2793386	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2793386	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2674718	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2674718	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	2793	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2675	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	44317266	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	29429281	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-30763948	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19631176	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13557011	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	9800780	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19385006	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12437034	usd
CY2023	kavl	Revenue Revenue	12395134	usd
CY2022	kavl	Revenue Revenue	12701539	usd
CY2023	kavl	Revenue From Related Party RevenueFromRelatedParty	10828	usd
CY2022	kavl	Revenue From Related Party RevenueFromRelatedParty	68139	usd
CY2023	kavl	Royalty Revenue RoyaltyRevenue	780929	usd
CY2022	kavl	Royalty Revenue RoyaltyRevenue	117292	usd
CY2023	kavl	Excise Tax On Products ExciseTaxOnProducts	99873	usd
CY2022	kavl	Excise Tax On Products ExciseTaxOnProducts	125513	usd
CY2023	us-gaap	Revenues Revenues	13087018	usd
CY2022	us-gaap	Revenues Revenues	12761457	usd
CY2023	kavl	Cost Of Revenue Related Party CostOfRevenueRelatedParty	10512423	usd
CY2022	kavl	Cost Of Revenue Related Party CostOfRevenueRelatedParty	11345912	usd
CY2023	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	0	usd
CY2022	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	174520	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	10512423	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	11520432	usd
CY2023	us-gaap	Gross Profit GrossProfit	2574595	usd
CY2022	us-gaap	Gross Profit GrossProfit	1241025	usd
CY2023	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	2450721	usd
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	2679308	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10787775	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12950373	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	13238496	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	15629681	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-466523	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	4	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-466523	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11130424	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14388652	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2348	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-18317	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-11132772	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-14370335	usd
CY2023	kavl	Preferred Stock Dividend PreferredStockDividend	112500	usd
CY2022	kavl	Preferred Stock Dividend PreferredStockDividend	-0	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11245272	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14370335	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.13
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.13
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.60
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-7.60
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2721080	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2721080	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1890971	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1890971	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16324313	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16324313	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	172379	usd
CY2022	kavl	Common Shares Settled And Cancelled CommonSharesSettledAndCancelled	-59862	usd
CY2022	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	65323	usd
CY2022	kavl	Exercise Of Common Stock Warrants ExerciseOfCommonStockWarrants	1625650	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	6043312	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-14370335	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	9800780	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	9800780	usd
CY2023	kavl	Common Shares Issued For Purchase Of Intangible Assets CommonSharesIssuedForPurchaseOfIntangibleAssets	1119800	usd
CY2023	kavl	Preferred Series B Shares Issued For Purchase Of Intangible Assets PreferredSeriesBSharesIssuedForPurchaseOfIntangibleAssets	9047980	usd
CY2023	kavl	Stock Warrants Issued For Purchase Of Intangible Assets StockWarrantsIssuedForPurchaseOfIntangibleAssets	1264396	usd
CY2023	kavl	Common Shares Issued For Services CommonSharesIssuedForServices	51510	usd
CY2023	kavl	Common Shares Issued For Loan CommonSharesIssuedForLoan	130478	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	3168430	usd
CY2023	kavl	Stock Issued During Period Value Stock Warrant Expense StockIssuedDuringPeriodValueStockWarrantExpense	218909	usd
CY2023	kavl	Preferred Stock Dividends Income Statements Impact PreferredStockDividendsIncomeStatementsImpact	112500	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-11132772	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13557011	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13557011	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-11132772	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-14370335	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	237702	usd
CY2023	kavl	Stock Options Expense StockOptionsExpense	3168430	usd
CY2022	kavl	Stock Options Expense StockOptionsExpense	6043312	usd
CY2023	kavl	Stock Warrants Expense StockWarrantsExpense	218909	usd
CY2022	kavl	Stock Warrants Expense StockWarrantsExpense	0	usd
CY2023	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	328304	usd
CY2022	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	0	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	463160	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	47727	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2023	kavl	Rou Operating Lease Expense RouOperatingLeaseExpense	190541	usd
CY2022	kavl	Rou Operating Lease Expense RouOperatingLeaseExpense	132890	usd
CY2023	us-gaap	Inventory Lifo Reserve Effect On Income Net InventoryLIFOReserveEffectOnIncomeNet	381512	usd
CY2022	us-gaap	Inventory Lifo Reserve Effect On Income Net InventoryLIFOReserveEffectOnIncomeNet	0	usd
CY2023	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	105057	usd
CY2022	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	259563	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1342397	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1410580	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-3704132	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	3704132	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-325739	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	106876	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3318668	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-13827082	usd
CY2023	kavl	Increase Decrease In Inventory Deposit Related Party IncreaseDecreaseInInventoryDepositRelatedParty	0	usd
CY2022	kavl	Increase Decrease In Inventory Deposit Related Party IncreaseDecreaseInInventoryDepositRelatedParty	2925000	usd
CY2023	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-1607302	usd
CY2022	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-146292	usd
CY2023	kavl	Increase Decrease In Account Payable IncreaseDecreaseInAccountPayable	334309	usd
CY2022	kavl	Increase Decrease In Account Payable IncreaseDecreaseInAccountPayable	-202806	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	2474817	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-12667769	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-475463	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	519553	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-235274	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	235274	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-44973	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	44973	usd
CY2023	kavl	Increase Decrease In Customer Refund Due IncreaseDecreaseInCustomerRefundDue	-392406	usd
CY2022	kavl	Increase Decrease In Customer Refund Due IncreaseDecreaseInCustomerRefundDue	316800	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-166052	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-118633	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2973254	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5705130	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3480	usd
CY2023	kavl	Transaction Acquisition Costs TransactionAcquisitionCosts	312289	usd
CY2022	kavl	Transaction Acquisition Costs TransactionAcquisitionCosts	-0	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-315769	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1625650	usd
CY2022	kavl	Settled Rsus With Cash SettledRsusWithCash	59862	usd
CY2023	us-gaap	Proceeds From Construction Loans Payable ProceedsFromConstructionLoansPayable	1272980	usd
CY2022	us-gaap	Proceeds From Construction Loans Payable ProceedsFromConstructionLoansPayable	0	usd
CY2023	kavl	Payments For Proceeds From Loans Payable PaymentsForProceedsFromLoansPayable	1136191	usd
CY2022	kavl	Payments For Proceeds From Loans Payable PaymentsForProceedsFromLoansPayable	-0	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	136789	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1565788	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-3152234	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-4139342	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3685893	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7825235	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	533659	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3685893	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	3363	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023	us-gaap	Stock Issued1 StockIssued1	1119800	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2023	kavl	Common Shares Issued For Servicestransaction Cost CommonSharesIssuedForServicestransactionCost	51510	usd
CY2022	kavl	Common Shares Issued For Servicestransaction Cost CommonSharesIssuedForServicestransactionCost	0	usd
CY2023	kavl	Preferred Stock Series B Shares Issued For Intangible Asset PreferredStockSeriesBSharesIssuedForIntangibleAsset	9047980	usd
CY2022	kavl	Preferred Stock Series B Shares Issued For Intangible Asset PreferredStockSeriesBSharesIssuedForIntangibleAsset	0	usd
CY2023	kavl	Stock Warrants Issued For Intangible Asset StockWarrantsIssuedForIntangibleAsset	1264396	usd
CY2022	kavl	Stock Warrants Issued For Intangible Asset StockWarrantsIssuedForIntangibleAsset	0	usd
CY2023	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	112500	usd
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	usd
CY2023	kavl	Insurance Financed By Third Party InsuranceFinancedByThirdParty	330000	usd
CY2023	kavl	Common Stock Issued For Note Payable Financing CommonStockIssuedForNotePayableFinancing	130478	usd
CY2023	kavl	Conversion Of Series Preferred Stock Shares To Common Stock Shares ConversionOfSeriesPreferredStockSharesToCommonStockShares	0	usd
CY2022	kavl	Conversion Of Series Preferred Stock Shares To Common Stock Shares ConversionOfSeriesPreferredStockSharesToCommonStockShares	25000	usd
CY2023	kavl	New Rou Leased Asset Recognized NewRouLeasedAssetRecognized	0	usd
CY2022	kavl	New Rou Leased Asset Recognized NewRouLeasedAssetRecognized	1276255	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_z2lWr74jNXy1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span style="text-decoration: underline"><span id="xdx_86C_zjRgmTpGiZ1f">Use of Estimates</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. In the opinion of management, all adjustments necessary in order to make the financial statements not misleading have been included. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023	kavl	Royalty Rate Discription RoyaltyRateDiscription	The royalty paid by PMPSA to KBI will no longer be based on sales price of the Product being sold, but rather on the volume of liquid contained within Product being sold. The royalty will be on a sliding scale of between $0.08 to $0.16 per sale based on the volume of liquid contained in the Product, increasing to between $0.10 to $0.20 per sale upon meeting certain sales milestones.
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	usd
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	252586	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	2912793	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q4	kavl	Accounts Receivable Noncurrentaccrual AccountsReceivableNoncurrentaccrual	113243	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	105057	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	usd
CY2023Q4	us-gaap	Customer Deposits Current CustomerDepositsCurrent	0	usd
CY2022Q4	us-gaap	Customer Deposits Current CustomerDepositsCurrent	44973	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	0	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	235274	usd
CY2023Q4	kavl	Refunds Due To Various Customers RefundsDueToVariousCustomers	392406	usd
CY2022Q4	kavl	Refunds Due To Various Customers RefundsDueToVariousCustomers	0	usd
CY2023	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	1986970	usd
CY2023	kavl	Revenue From Sale RevenueFromSale	1842511	usd
CY2022	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	3945534	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	23800000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	200000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	7319289	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	4286289	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	kavl	Common Shares Issued For Intangible Assets CommonSharesIssuedForIntangibleAssets	1119800	usd
CY2023Q2	us-gaap	Asset Acquisition Consideration Transferred Transaction Cost AssetAcquisitionConsiderationTransferredTransactionCost	568672	usd
CY2023Q2	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	11795975	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	11795975	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	327666	usd
CY2023Q4	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P15Y
CY2023	us-gaap	Finite Lived Intangible Asset Weighted Average Period Before Next Renewal Or Extension FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension	P14Y7M6D
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths	786398	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	786398	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	786398	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour	786398	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive	786398	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive	7536319	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11468309	usd
CY2023Q4	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	800000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1160000	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	134176	usd
CY2023Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	8681	usd
CY2023	kavl	Commitment Fee Shares CommitmentFeeShares	19048	shares
CY2021Q4	us-gaap	Description Of Lessee Leasing Arrangements Operating Leases DescriptionOfLesseeLeasingArrangementsOperatingLeases	the Company entered into a month-to-month lease agreement with Ranger Enterprises, LLC, located in Seymour, Indiana, to store product inventory at this satellite location. The Company made payments on this lease in the amount of $19,959. The lease was terminated in June 2022.
CY2021Q4	us-gaap	Description Of Lessee Leasing Arrangements Operating Leases DescriptionOfLesseeLeasingArrangementsOperatingLeases	the Company entered into a month- to-month lease agreement with FFE Solutions Group, located in Salt Lake City Utah, to store additional product inventory at this satellite location. The Company made payments on this lease in the amount of $19,108. This lease was terminated in April 2022.
CY2023Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.045	pure
CY2023	us-gaap	Proceeds From Lease Payments ProceedsFromLeasePayments	-190541	usd
CY2022	us-gaap	Proceeds From Lease Payments ProceedsFromLeasePayments	-118633	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1008428	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1198969	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	184568	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	166051	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	866207	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1050776	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1050775	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1216827	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths	228133	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	238800	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree	253614	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Four LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour	274946	usd
CY2023Q4	kavl	Lessee Operating Lease Liability Payments Due After Rolling Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFour	175989	usd
CY2023Q4	kavl	Total Future Undiscounted Lease Payments TotalFutureUndiscountedLeasePayments	1171482	usd
CY2023Q4	kavl	Lessee Operatings Lease Liability Undiscounted Excess Amount LesseeOperatingsLeaseLiabilityUndiscountedExcessAmount	120707	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1050775	usd
CY2023	kavl	Common Stock Share Issued CommonStockShareIssued	95239	shares
CY2022	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	65323	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	237702	usd
CY2022Q4	kavl	Obligations Value ObligationsValue	59862	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P10Y
CY2022	kavl	Unrecognized Expenses Related To Options UnrecognizedExpensesRelatedToOptions	1716795	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P9Y6M7D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	50000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	3168430	usd
CY2023	kavl	Unrecognized Expenses Related To Options UnrecognizedExpensesRelatedToOptions	3904525	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P8Y11M26D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1564166	shares
CY2021Q3	kavl	Warrants Purchase WarrantsPurchase	193036	shares
CY2021Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	39.90
CY2022	kavl	Warrants Exercised Shares WarrantsExercisedShares	40743	shares
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1625650	usd
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	14.70
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	2.4320	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	2.4790	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0381	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0418	pure
CY2022Q4	kavl	Accounts Payable Related Parties AccountsPayableRelatedParties	0	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.35	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.04458	pure
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	2348	usd
CY2022	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	-18317	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2348	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-18317	usd
CY2023	kavl	Federal Federal	0	usd
CY2022	kavl	Federal Federal	0	usd
CY2023	kavl	State State	0	usd
CY2022	kavl	State State	0	usd
CY2023	kavl	Total Deferred Tax Expense TotalDeferredTaxExpense	0	usd
CY2022	kavl	Total Deferred Tax Expense TotalDeferredTaxExpense	0	usd
CY2023	kavl	Federal Tax Provision FederalTaxProvision	0	usd
CY2022	kavl	Federal Tax Provision FederalTaxProvision	0	usd
CY2023	kavl	State Tax Provision StateTaxProvision	2348	usd
CY2022	kavl	State Tax Provision StateTaxProvision	-18317	usd
CY2023	kavl	Total Tax Provision TotalTaxProvision	2348	usd
CY2022	kavl	Total Tax Provision TotalTaxProvision	-18317	usd
CY2023Q4	kavl	Stock Compensation Expense Nqso StockCompensationExpenseNqso	2069641	usd
CY2022Q4	kavl	Stock Compensation Expense Nqso StockCompensationExpenseNqso	1694324	usd
CY2023Q4	kavl	Other Other	499203	usd
CY2022Q4	kavl	Other Other	362170	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4998800	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2582061	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7567644	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4638555	usd
CY2023Q4	kavl	Deferred Prepaid Expense DeferredPrepaidExpense	27497	usd
CY2022Q4	kavl	Deferred Prepaid Expense DeferredPrepaidExpense	92420	usd
CY2023Q4	kavl	Deferred Right Of Use Asset DeferredRightOfUseAsset	-220859	usd
CY2022Q4	kavl	Deferred Right Of Use Asset DeferredRightOfUseAsset	-259866	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	248356	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	352286	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7319288	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4286269	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1985	shares
CY2021Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	602.28
CY2022	kavl	Stock Options Expense1 StockOptionsExpense1	190000	usd
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	21.63
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	33871	usd
CY2022Q4	kavl	Settlement Amount SettlementAmount	150000	usd
CY2023	kavl	Bonus Description BonusDescription	cash bonus award equal to $30,000 for every $25 million in gross revenues generated by the Company. With respect to the Chief Operating Officer, the Board approved a cash bonus award equal to $20,000 for every $25 million in gross revenues generated by the Company. On May 28, 2020, the Board also approved an equity bonus award for each of the Chief Executive Officer and the Chief Operating Officer. With respect to the Chief Executive Officer, the Board approved an award of 358 restricted shares of the Common Stock for every $50 million in accumulated gross revenues generated by the Company. With respect to the Chief Operating Officer, the Board approved an award of 298 restricted shares of the Common Stock for every $50 million in accumulated gross revenues generated by the Company.
CY2022Q2	kavl	Cash Bonuses CashBonuses	125000000	usd
CY2022Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	50000	usd
CY2023	us-gaap	Business Acquisitions Purchase Price Allocation Year Of Acquisition Net Effect On Income BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncome	81300	usd

Files In Submission

Name	View Source	Status
0001731122-24-000237-index-headers.html	Edgar Link	pending
0001731122-24-000237-index.html	Edgar Link	pending
0001731122-24-000237.txt	Edgar Link	pending
0001731122-24-000237-xbrl.zip	Edgar Link	pending
e5407_10k.htm	Edgar Link	pending
e5407_ex10-29.htm	Edgar Link	pending
e5407_ex19-1.htm	Edgar Link	pending
e5407_ex21-1.htm	Edgar Link	pending
e5407_ex23-1.htm	Edgar Link	pending
e5407_ex31-1.htm	Edgar Link	pending
e5407_ex31-2.htm	Edgar Link	pending
e5407_ex32-1.htm	Edgar Link	pending
e5407_ex32-2.htm	Edgar Link	pending
e5407_ex4-1.htm	Edgar Link	pending
e5407_ex97-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
kavl-20231031.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
kavl-20231031_cal.xml	Edgar Link	unprocessable
e5407_10k_htm.xml	Edgar Link	completed
kavl-20231031_lab.xml	Edgar Link	unprocessable
kavl-20231031_pre.xml	Edgar Link	unprocessable
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
kavl-20231031_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KAVL
Kaival Brands Innovations Group, Inc. Stock $kavl

2024 Q1 Form 10-K Financial Statement

#000173112224000237 Filed on February 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KAVL Kaival Brands Innovations Group, Inc. Stock $kavl

2024 Q1 Form 10-K Financial Statement

#000173112224000237 Filed on February 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KAVL
Kaival Brands Innovations Group, Inc. Stock $kavl